DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

BMO Capital Initiates Coverage On Biomarin Pharmaceutical with Market Perform Rating, Announces $94 Price Target

BMO Capital analyst George Farmer initiates coverage on Biomarin Pharmaceutical (NASDAQ:BMRN) with a Market Perform rating and a $94 price target.

Benzinga · 01/28/2020 11:52

BMO Capital analyst George Farmer initiates coverage on Biomarin Pharmaceutical (NASDAQ:BMRN) with a Market Perform rating and a $94 price target.